# Mitokyne, Inc.: Form D filing

Mitokyne, Inc., a pharmaceuticals company in Boston, MA, filed a Form D with the SEC in 2013. The latest, on October 17, 2013, reports $5.2 million sold of a $45 million offering to 4 investors.

Find out what Mitokyne, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Mitokyne%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Mitokyne%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmitokyne-inc-1589455)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Mitokyne%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Mitokyne%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmitokyne-inc-1589455)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: C/O MPM CAPITAL, 200 CLARENDON STREET, 54TH FLOOR, Boston, MA, 02116
- Phone: (617) 425-9200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2011
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1589455

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 17, 2013 | New notice | $45,000,000 | $5,222,321 | $39,777,679 | 4 | Oct 4, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1589455/000158945513000001/0001589455-13-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kazumi Shiosaki | Executive Officer, Director |  |
| Ansbert Gadicke | Director |  |
| Sakae Asanuma | Director |  |
| Richard Aldrich | Director |  |
| David Cordo | Executive Officer |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of Oct 14, 2013](https://specstream.ai/data/form-d/week/2013-10-14) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Mitokyne, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).